title: Burning mouth in Parkinson's disease sufferers.
abstract: OBJECTIVE
  The purpose of the study was to determine the prevalence of burning mouth (BM) in a population of Parkinson's Disease (PD) sufferers and also to assess the use of pain profiles in identifying the type of burning sensation experienced.
  
  
  METHODS
  Subjects were surveyed by means of a one shot postal questionnaire for which ethical approval had previously been granted. Anonymity was guaranteed and therefore no attempt was made to follow up non-respondents.
  
  
  RESULTS
  BM was reported by 24% of respondents. The pain profiles were completed by 17 BM sufferers.
  
  
  CONCLUSIONS
  Burning mouth is reported to occur in 24% of PD sufferers which is 5 times greater than that of the general population. The reason for this is uncertain but the result has implications for the future care of PD patients and indicates the need for increased dental input at PD outpatient clinics.
authors.affiliation: Pain Relief Foundation (NI), School of Clinical Dentistry, Queen's University of Belfast, UK. t.clifford@qub.ac.uk
authors.forename: T J
authors.initials: TJ
authors.lastname: Clifford
authors.forename: M J
authors.initials: MJ
authors.lastname: Warsi
authors.forename: C A
authors.initials: CA
authors.lastname: Burnett
authors.forename: P J
authors.initials: PJ
authors.lastname: Lamey
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000978:Antiparkinson Agents / Q000009:adverse effects; D002054:Burning Mouth Syndrome / Q000150:complications* / Q000453:epidemiology / Q000209:etiology; D017742:Dental Care for Chronically Ill; D005260:Female; D006801:Humans; D007980:Levodopa / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009660:Northern Ireland / Q000453:epidemiology; D010300:Parkinson Disease / Q000150:complications* / Q000188:drug therapy; D015995:Prevalence; D012494:Sampling Studies
chemical_list: D000978:Antiparkinson Agents; D007980:Levodopa